| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 11/08/2001 | CA2407709A1 Regulated antigen delivery system (rads) involving bacteria |
| 11/08/2001 | CA2407614A1 Dried microorganism cell product by spray-drying |
| 11/08/2001 | CA2399288A1 Process for the preparation of alkaline earth salts of d-pantothenic acid |
| 11/07/2001 | EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 11/07/2001 | EP1151133A1 Stereoselective synthesis of nucleoside analogues |
| 11/07/2001 | EP1151131A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 11/07/2001 | EP1151129A2 Methods of making compounds |
| 11/07/2001 | EP1151126A1 Biocatalytic synthesis of shikimic acid |
| 11/07/2001 | EP1151125A1 Biocatalytic synthesis of quinic acid and conversion to hydroquinone |
| 11/07/2001 | EP1151112A1 Heat-inducible promoter |
| 11/07/2001 | EP1151102A1 Glycosylated leptin compositions and related methods |
| 11/07/2001 | EP1151088A1 Improved phytases |
| 11/07/2001 | EP1151085A2 Nucleic acid molecules encoding alternansucrase |
| 11/07/2001 | EP1151083A1 Nitroreductase enzymes |
| 11/07/2001 | EP1151082A1 Sebocytes, sebocyte cell lines and applications thereof |
| 11/07/2001 | EP1150922A1 Method for treating a waste stream using photosynthetic microorganisms |
| 11/07/2001 | EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 11/07/2001 | EP1150652A1 Skin lightening agents |
| 11/07/2001 | EP1150577A1 Improved microbial preparations |
| 11/07/2001 | EP0689596B1 Stimulation of immune response by viral protein |
| 11/07/2001 | CN1321199A Cell lines for propagation of mutated herpes viruses |
| 11/07/2001 | CN1321195A Peptidyl prolyl cis-trans isomerases |
| 11/07/2001 | CN1321194A Transgenic amorpha-4,11-diene synthesis |
| 11/07/2001 | CN1321192A Novel strains of bacillus subtilis group for food fermentation |
| 11/07/2001 | CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
| 11/07/2001 | CN1320706A Method for preparing guanosines compounds and its intermidiates |
| 11/07/2001 | CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide |
| 11/07/2001 | CN1074455C Vegetable oil enzymatic degumming process by means of aspergillus phospholipase |
| 11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
| 11/07/2001 | CN1074255C Spray-drying process |
| 11/06/2001 | US6313378 Transgenic plant for use in biological pest control |
| 11/06/2001 | US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae |
| 11/06/2001 | US6313276 Human endothelin receptor |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313264 Effector proteins of Rapamycin |
| 11/06/2001 | US6313263 γ, δ T cell receptor and methods for detection |
| 11/06/2001 | US6313128 Can be used as lypolysis/lypogenesis regulators in the skin without, interferring with the skin's natural functions; for therapy of saborrhea and acne |
| 11/06/2001 | US6313069 Herbicides |
| 11/06/2001 | US6312955 Isolating chemical resistant microorganism; culture microorganisms in nutrient broth containing chemical, recover resistant bacteria |
| 11/06/2001 | US6312951 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 11/06/2001 | US6312946 Viable contaminant particle free adenoviruses, their prepartion and use |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312936 Enzymatic polypeptide for use in the treatment of animal feeds and textiles |
| 11/06/2001 | US6312918 Evaluating humans for camyobacter infection; recover gas from stomach and monitor amount of ammonia and methylamine |
| 11/06/2001 | US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays |
| 11/06/2001 | US6312903 Simulataneous detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 11/06/2001 | US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation |
| 11/06/2001 | US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
| 11/06/2001 | US6312689 Antibodies or antigens |
| 11/06/2001 | US6312683 Equine infectious anemia virus vectors |
| 11/01/2001 | WO2001081920A2 Comparative phenotype analysis for assessment of biologically active compounds |
| 11/01/2001 | WO2001081615A1 Composition and method for detecting and early and differentiated counting of gram-negative microorganisms |
| 11/01/2001 | WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance |
| 11/01/2001 | WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 11/01/2001 | WO2001080663A1 Animal feed additives and method of producing the same |
| 11/01/2001 | WO2001038484A3 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 11/01/2001 | WO2000043523A3 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 11/01/2001 | WO2000039276A9 Microbial transformation method for the preparation of an epothilone |
| 11/01/2001 | WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 11/01/2001 | US20010037514 Oil containing triglyceride having a 1,3-dierycoyl 2-oleoyl glycerol content of at least 50%; transgenic plants for producing seeds; lubricant additives; hydraulic oils |
| 11/01/2001 | US20010036660 Reacting a a-keto acid with methylamine |
| 11/01/2001 | EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 11/01/2001 | CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 11/01/2001 | CA2403916A1 Viral vectors for use in monitoring hiv drug resistance |
| 11/01/2001 | CA2377242A1 Composition and method for detecting and early and differentiated counting of gram-negative microorganisms |
| 10/31/2001 | EP1149919A2 Genes related to biosynthesis of ML-236B |
| 10/31/2001 | EP1149918A1 Process for the oxidation of hydrocarbons by use of microorganisms |
| 10/31/2001 | EP1149913A1 Cytokine immunoconjugates |
| 10/31/2001 | EP1149911A2 Amino acid producing strains belonging to the genus Escherichia and method for producing amino acid |
| 10/31/2001 | EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 10/31/2001 | EP1149908A1 TGF-beta type receptor cDNAs and uses thereof |
| 10/31/2001 | EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 10/31/2001 | EP1149164A2 Neisseria meningitidis polypeptides |
| 10/31/2001 | EP1149163A2 Human serum albumin |
| 10/31/2001 | EP1148785A1 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms |
| 10/31/2001 | EP0870051B1 Production of ammonium acrylate |
| 10/31/2001 | EP0842279B1 Helper viruses for preparing recombinant viral vectors |
| 10/31/2001 | EP0803065B1 A-protein as a diagnostic of cancer |
| 10/31/2001 | EP0779896B1 New process for the production of biologically active protein (tgf) |
| 10/31/2001 | EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 10/31/2001 | EP0444181B1 C-erbb-2 external domain: gp75 |
| 10/31/2001 | EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications |
| 10/31/2001 | DE10019861A1 Neues Synthesezwischenprodukt, seine mikrobiologische Herstellung und Verwendung zur Synthese von Vitamin D-Derivaten A new synthetic intermediate, its microbiological production and use for the synthesis of vitamin D derivatives |
| 10/31/2001 | DE10014708A1 Verfahren zur Identifizierung und Anreicherung von zellspezifischen Zielstrukturen Method for the identification and enrichment of cell-specific target structures |
| 10/31/2001 | DE10014685A1 Verfahren zur Identifizierung von zellspezifischen Zielstrukturen A method for identifying cell-specific target structures |
| 10/31/2001 | CN1319668A Nucleotide sequence of code dap C gene and process for producing L-lysine |
| 10/31/2001 | CN1319667A Novel nucleotide sequence of code ptsH gene |
| 10/31/2001 | CN1073806C Composition and method for controlling plant diseases |
| 10/30/2001 | US6310272 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 10/30/2001 | US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers |
| 10/30/2001 | US6309856 Human MAD proteins and uses thereof |
| 10/30/2001 | US6309846 Evaluating humans with cancer; perform immunoassays over time to determine adjustment in preferential antigen concentration, ajustment in antigen concentration indicates adjustment in cancer classification |
| 10/30/2001 | US6309841 Expression vector for the generation of stable genetically engineered polypeptides |
| 10/30/2001 | US6309834 Detecting homogeneity in nucleotide sequences; generate clones in cells, generate ribonucleic acids, amplify and resolve nucleotide sequences, clone preferential sequences into plasmid, determine sequence of preferential clones |
| 10/30/2001 | US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host. |
| 10/30/2001 | US6309641 Which can be used immunologically as a vaccine for leptospirosis caused by this organism. |
| 10/30/2001 | US6309638 Netrins |
| 10/30/2001 | CA2227308C Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 10/30/2001 | CA2214579C Subtilisin dy variants having decreased adsorption and increased hydrolysis |
| 10/30/2001 | CA2170491C Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |